Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Diseases Market 2025-2029 - Analysis and Forecasts by Syndrome, Plex, Place and Country, with Executive Guides" has been added to ResearchAndMarkets.com's offering.
The Molecular Diagnostics - Infectious Disease sector is set to experience significant growth, driven by advancements in biotechnology and genomics. This comprehensive report provides an in-depth analysis of the market trends and technological developments disrupting the traditional approaches to diagnosis and treatment, promising to revolutionize the industry and mitigate antimicrobial resistance threats.
The acceleration of infectious disease testing is largely attributed to the advancements in biotechnology, particularly genomics. Our report delves into the myriad of dynamic trends fueling market expansion and enhancing company valuations. Stakeholders can gain a strategic advantage with insights into these emerging trends.
One of the most significant promising advancements lies in the evolving interplay between nucleic acid testing and immunoassay technology. These innovations are paving the way for a dynamic, expanding global market, positioning diagnostics at the forefront of the fight against infectious diseases. This report elucidates the cutting-edge technologies poised to lead infectious disease eradication efforts worldwide.
Contained within the report are exhaustive details, including up-to-date United States Medicare Fee Payment Schedules, offering valuable data for strategic pricing decisions. Moreover, purchasers gain access to reports with comprehensive data breakdowns for 15 countries across four regions, with additional detailed analyses available upon request for any country globally. This level of detail ensures that this report is an indispensable resource for strategic planning and market positioning.
Transform your organization's expertise with this authoritative research. By leveraging the extensive data and insights within, position your team as leaders in the rapidly evolving field of molecular diagnostics. Elevate your strategic initiatives and harness the potential of these remarkable technological advancements for superior market performance.
Companies Featured
- Acibadem Labmed Laboratory
- ACM Medical Laboratory
- Adicon Clinical Laboratories
- American Bio-Clinical Laboratories, Int'l
- ARUP Laboratories
- Ascend Clinical
- Assurance Scientific Laboratories
- Atalan
- Avalon GloboCare
- Bio-Reference Laboratories
- Bionano Genomics
- Bioscientia Institut fur Medizinische Diagnostik GmbH
- BP Healthcare Group
- Brooks Automation
- Clinical Reference Laboratory
- Clongen Laboratories
- CompuGroup Medical
- CompuNet Clinical Laboratories
- Diagnosticos da America
- DIAN Diagnostics Co., Ltd.
- EDGC
- EKF Diagnostics
- Enzo Biochem
- Eone Laboratories
- Eurofins Scientific
- Exagen Diagnostics
- Genzyme Corporation
- Gribbles Pathology
- Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Integrated Regional Laboratories
- Karius
- KDL Group
- Labcorp
- Laboratory Corporation of America
- Lifelabs
- Lucid Diagnostics
- Mayo Clinic Laboratories
- MedGenome
- Mid America Clinical Laboratories
- MNG Labs
- Molecular Health
- Myriad Genetics/Myriad RBM
- Natera
- NeoGenomics
- OncoDNA
- Pathology, Inc.
- ProPhase Labs
- Psychemedics Corporation
- Quest Diagnostics
- Q Solutions
- RDL Reference Laboratory
- Seegene
- Siemens Healthineers
- Sonic Healthcare
- Sophia Genetics
- Spectra Laboratories
- Synlab
- Sysmex Inostics
- Thermo Fisher
- TruDiagnostic
- Unilabs
- Vision Medicals
- Werfen
For more information about this report visit https://www.researchandmarkets.com/r/6zp5kb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
